Synonym |
TRH, Thyrotropin-releasing hormone |
Species |
Human |
Protein Accession |
P20396 |
Purity |
≥ 95% |
Endotoxin Level |
< 1.0 EU/μg |
Biological Activity |
Fully biologically active when compared to standard |
Expression System |
E. coli |
Fusion Tag |
His-tag |
Predicted Molecular Mass |
3644 Da |
Formulation |
Lyophilized from a 0.2 μm filtered solution in 30% acetonitrile and 0.1% trifluoroacetic acid
|
Reconstitution |
Centrifuge the vial prior to opening. Reconstitute in 1% acetic acid to a concentration of
0.1-1.0 mg/ml |
Storage & Stability |
Store at -20°C. Repeated freeze-thaw cycles should be avoided. |
FAQ
What is Cyclo(Trp-Trp) and how does it work?
Cyclo(Trp-Trp), also known as
cyclo-tryptophan-tryptophan, is a cyclic dipeptide composed of two tryptophan amino acids linked
together. As a dipeptide, it exists as an intermediate between peptides and proteins, featuring
interesting biochemical properties that make it a molecule of great interest in research and therapeutic
applications. The cyclization of its structure gives it specific stability and unique properties
compared to its linear counterparts, which impacts its biological activity significantly.
The
mechanism through which Cyclo(Trp-Trp) works can be attributed to its structural features, which
influence its ability to interact with other molecules within biological systems. It's known to possess
hydrophobic characteristics due to the indole side chains of tryptophan, which makes it interact readily
with lipid membranes. This interaction enhances its permeability and potential for bioavailability,
allowing it to affect cellular processes efficiently.
Cyclo(Trp-Trp) is studied for its potential
role as an antioxidant, which stems from the inherent properties of tryptophan molecules. The indole
groups found in tryptophan are capable of neutralizing free radicals, thus protecting cells from
oxidative stress and damage. Research into its antioxidant capacity explores its utility in minimizing
oxidative damage linked to various diseases, including neurodegenerative conditions.
Furthermore,
Cyclo(Trp-Trp) has been investigated for its antimicrobial properties. Cyclic peptides often show
enhanced ability to permeate microbial cell walls, allowing them to disrupt essential cellular functions
within bacteria and fungi. This antimicrobial effect is being explored for possible applications in
developing new treatments for antibiotic-resistant infections, an area of increasing concern in the
medical community.
Cyclo(Trp-Trp) also holds significance in drug delivery systems. Its stability
and ability to traverse biological barriers make it a suitable candidate for carrying therapeutic agents
to target locations within the organism. Researchers are keen on modifying and testing this molecule as
a carrier to improve the delivery efficiency of drugs, enhancing their effectiveness, and minimizing
side effects.
The exact functionality of Cyclo(Trp-Trp) is still under extensive research, and
understanding its interaction at the molecular level with biological components is critical. Its
potential roles are diverse, spanning from therapeutic applications as a standalone molecule to serving
as a component in more complex therapeutic systems.
What are the possible applications of
Cyclo(Trp-Trp) in medicine?
Cyclo(Trp-Trp) is attracting immense interest within medical research
due to its array of potential applications. As a molecule with inherent bioactive properties, it holds
promise for use in multiple therapeutic areas, spurred by its unique characteristics as a cyclic
dipeptide.
One promising application of Cyclo(Trp-Trp) is in the field of antioxidant therapy.
Given its capability to neutralize reactive oxygen species (ROS), it is being studied for its potential
to limit oxidative stress-related damage in various conditions. Oxidative stress is implicated in the
pathogenesis of several diseases, including cardiovascular diseases, neurodegenerative diseases like
Alzheimer’s and Parkinson’s, and even cancer. Using Cyclo(Trp-Trp) could offer a therapeutic advantage
by minimizing the harmful impacts of free radicals, thus providing a protective effect against disease
progression.
Additionally, Cyclo(Trp-Trp) shows considerable promise in antimicrobial therapy.
Its distinctive ability to permeate microbial cell walls due to its structure can potentially be
employed to combat antibiotic-resistant strains of bacteria. This is particularly crucial in an era
where antibiotic resistance is becoming a global health challenge, necessitating innovative solutions to
tackle resistant pathogens. The ongoing studies aim to develop Cyclo(Trp-Trp)-based treatments that can
either replace or supplement conventional antibiotics, thus enhancing antimicrobial
efficacy.
Moreover, the molecule is being explored for its role in neuroprotection. The brain is
especially vulnerable to oxidative damage, given its high oxygen consumption and lipid-rich environment.
Cyclo(Trp-Trp)’s antioxidant properties make it a candidate for treatments against neurodegenerative
diseases, where oxidative damage plays a critical role in disease progression. Research in this area
aims to establish whether it can not only protect neurons from oxidative damage but also influence
recovery and regeneration.
Cyclo(Trp-Trp) is also being investigated as a functional component in
drug delivery systems. Its structural stability and ability to cross cell membranes make it suitable for
use as a carrier molecule. This provides an exciting opportunity to enhance drug delivery efficiency,
targeting drugs more precisely to their sites of action, and potentially reducing side effects by
lowering necessary dosages.
In cancer therapy, there is active research on exploiting its
structure for use as a chemotherapeutic agent or adjuvant. It holds the potential to improve the
selective targeting of cancer cells, thereby improving the therapeutic index of anticancer
drugs.
Current research continues to reveal insights into the diverse potential applications of
Cyclo(Trp-Trp) in medical science, with encouraging progress in translating these applications from
bench to bedside. The breadth of its potential uses underscores the need for further studies to fully
realize its scope and therapeutic benefits.
Could Cyclo(Trp-Trp) serve as a dietary
supplement?
Cyclo(Trp-Trp) as a dietary supplement is an intriguing concept that is being
explored due to its potential health benefits and bioactive properties. The proposition of using it as a
supplement hinges on its inherent capabilities as an antioxidant, its stability, and its possible role
in improving overall health. However, the notion of including Cyclo(Trp-Trp) in dietary supplements
requires careful consideration of several important factors.
Firstly, the antioxidant properties
of Cyclo(Trp-Trp) make it a candidate for supplementation aimed at reducing oxidative stress in the
body. Antioxidants are vital for neutralizing free radicals, unstable molecules that can cause cellular
damage when left unchecked. This damage has been linked to aging and a host of chronic diseases. By
potentially offering protection against oxidative damage, Cyclo(Trp-Trp) could serve to bolster the
body's defense system, contributing to improved health and longevity.
Furthermore, there is
interest in its ability to support immune function. The body's immune system relies on antioxidants to
function properly and combat pathogens effectively. By supplementing with Cyclo(Trp-Trp), it's possible
that individuals could maintain a more robust immune response, thereby reducing susceptibility to
infections or disease.
Nevertheless, the transition of Cyclo(Trp-Trp) from a research molecule to
a dietary supplement is contingent upon thorough scientific validation. It is imperative that extensive
clinical studies be conducted to ascertain both the efficacy and safety of Cyclo(Trp-Trp) when consumed
as a supplement. Dosage, potential side effects, interactions with other medications, and long-term
health impacts need rigorous evaluation to ensure consumer safety and product efficacy.
Another
consideration would be the bioavailability of Cyclo(Trp-Trp) when administered orally. Determining its
absorption rate, how it's metabolized by the body, and how effectively it can reach its target tissues
are crucial factors that would influence its effectiveness as a dietary supplement. Modifications or
formulations that optimize its bioavailability might be necessary, which adds an additional layer of
complexity to its development as a consumer product.
Commercially, producing Cyclo(Trp-Trp) as a
supplement would also imply considerations around manufacturing, regulation, labeling, and distribution.
In many jurisdictions, dietary supplements must comply with regulatory requirements that govern efficacy
claims, labeling, and safety assurances. These ingredients should be validated by credible scientific
research to support any health claims made to the consumer.
Ultimately, while the potential is
promising, Cyclo(Trp-Trp) is still primarily a subject of scientific study. Should initial research and
clinical trials prove successful, it could indeed become a valuable addition to the repertoire of
dietary supplements available on the market, offering unique benefits attributed to its biochemical
properties. For those considering incorporating such supplements into their diet, it is advisable to
consult healthcare professionals who can provide guidance based on the most current scientific evidence
and individual health needs.
How does Cyclo(Trp-Trp) compare to other cyclic peptides in terms of
functionality?
Cyclo(Trp-Trp) belongs to a unique class of compounds known as cyclic peptides,
which are characterized by their cyclic structure. This structural arrangement endows them with several
functionalities distinct from linear peptides. When compared with other cyclic peptides, Cyclo(Trp-Trp)
shares many common advantages, yet it also brings unique properties and applications to the table due to
its specific composition.
Cyclic peptides as a whole are noted for their enhanced stability
compared to their linear counterparts. This stability is largely because the cyclic nature reduces the
number of terminal ends that are susceptible to proteolytic degradation. As a result, Cyclo(Trp-Trp),
like other cyclic peptides, generally retains its functionality in biological systems for longer
durations, thereby increasing its potential efficacy as a therapeutic agent or bioactive
compound.
Diversification within cyclic peptides often comes from the varying side chains of
constituent amino acids, which influence hydrophobicity, charge, and functional group availability.
Cyclo(Trp-Trp) distinguishes itself with its tryptophan content. The presence of two tryptophan residues
confers significant hydrophobic properties and introduces the opportunity for pi-stacking interactions
due to the aromatic indole rings. This allows for unique interactions with biological membranes and
possibly distinct binding capabilities with certain molecular targets, potentially functioning in ways
other cyclic peptides cannot.
Functionality across cyclic peptides is also impacted by the
specificity of their amino acid sequence and how they can interact with various proteins or cellular
receptors. Cyclo(Trp-Trp) is implicated in particular functions such as antioxidant activity, which is
attributed to tryptophan's capacity to scavenge free radicals. In comparison, other cyclic peptides may
exhibit vastly different activities depending on their makeup, including enzyme inhibition or immune
modulation.
Another consideration is the size and overall molecular weight of Cyclo(Trp-Trp)
compared to other cyclic peptides. Generally, smaller cyclic peptides like Cyclo(Trp-Trp) have the
advantage of better cell permeability and distribution, potentially allowing them to reach cellular
targets more efficiently. This feature may enhance its functional capabilities in pharmacological
applications, particularly in contexts where cellular uptake is critical for efficacy.
Moreover,
synthetic accessibility also plays a crucial role in the real-world application of cyclic peptides.
Cyclo(Trp-Trp) is accessible through established synthetic methods, which is beneficial for research
purposes and potential therapeutic development. This ease of synthesis contrasts with some larger or
more complex cyclic peptides, which might pose challenges in production and scalability.
In
summary, while Cyclo(Trp-Trp) shares many functional advantages with other cyclic peptides due to its
cyclic nature, its unique composition imparts additional distinct properties and functionalities.
Understanding the specific interactions and applications of Cyclo(Trp-Trp) continues to be an active
area of research, aimed at maximizing its potential in various fields ranging from therapeutics to
nutraceuticals.